Phage Resistance in Multidrug-Resistant Klebsiella pneumoniae ST258 Evolves via Diverse Mutations That Culminate in Impaired Adsorption.


Journal

mBio
ISSN: 2150-7511
Titre abrégé: mBio
Pays: United States
ID NLM: 101519231

Informations de publication

Date de publication:
28 01 2020
Historique:
entrez: 30 1 2020
pubmed: 30 1 2020
medline: 9 6 2020
Statut: epublish

Résumé

The evolution of phage resistance poses an inevitable threat to the efficacy of phage therapy. The strategic selection of phage combinations that impose high genetic barriers to resistance and/or high compensatory fitness costs may mitigate this threat. However, for such a strategy to be effective, the evolution of phage resistance must be sufficiently constrained to be consistent. In this study, we isolated lytic phages capable of infecting a modified

Identifiants

pubmed: 31992617
pii: mBio.02530-19
doi: 10.1128/mBio.02530-19
pmc: PMC6989104
pii:
doi:

Substances chimiques

Anti-Bacterial Agents 0
OmpC protein 0
Porins 0

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Références

J Biol Chem. 2005 Nov 4;280(44):36648-56
pubmed: 16131489
Antimicrob Agents Chemother. 2015 Oct;59(10):5873-84
pubmed: 26169401
Annu Rev Microbiol. 2019 Sep 8;73:155-174
pubmed: 31185183
J Biol Chem. 1977 Sep 25;252(18):6299-303
pubmed: 330527
Antimicrob Agents Chemother. 2016 Sep 23;60(10):5806-16
pubmed: 27431214
Annu Rev Microbiol. 1982;36:285-309
pubmed: 6293371
J Bacteriol. 1994 May;176(9):2611-8
pubmed: 8169209
Curr Opin Microbiol. 2019 Oct;51:46-50
pubmed: 31226502
Mol Biol Evol. 2014 Jan;31(1):232-8
pubmed: 24170494
Evolution. 2007 Jul;61(7):1695-709
pubmed: 17598749
PLoS One. 2012;7(3):e31698
pubmed: 22396736
J Bacteriol. 2003 Mar;185(5):1659-71
pubmed: 12591884
Evol Med Public Health. 2018 Mar 08;2018(1):60-66
pubmed: 29588855
Mol Microbiol. 1999 Mar;31(5):1321-32
pubmed: 10200954
Mol Gen Genet. 1987 Jan;206(1):110-5
pubmed: 3553859
J Virol. 1982 Jan;41(1):222-7
pubmed: 7045389
J Bacteriol. 2001 Jun;183(12):3564-73
pubmed: 11371519
Nucleic Acids Res. 2018 Jul 2;46(W1):W537-W544
pubmed: 29790989
J Bacteriol. 1975 Mar;121(3):983-93
pubmed: 1090611
J Biol Chem. 2004 Jul 2;279(27):27928-40
pubmed: 15090547
J Bacteriol. 1996 Aug;178(16):4885-93
pubmed: 8759852
Biochem Biophys Res Commun. 1962 Apr 3;7:121-5
pubmed: 13895791
J Biol Chem. 2001 Jan 26;276(4):2361-71
pubmed: 11053445
J Mol Biol. 1990 Nov 20;216(2):327-34
pubmed: 2147721
Viruses. 2018 Apr 10;10(4):
pubmed: 29642590
Annu Rev Biochem. 2006;75:39-68
pubmed: 16756484
J Bacteriol. 1982 Aug;151(2):718-22
pubmed: 7047495
J Bacteriol. 2017 Sep 19;199(20):
pubmed: 28760848
J Biol Chem. 2017 Nov 3;292(44):17981-17990
pubmed: 28878019
Microbiol Rev. 1993 Sep;57(3):655-82
pubmed: 7504166
Carbohydr Res. 2013 Mar 22;369:6-9
pubmed: 23360863
J Bacteriol. 1995 Apr;177(7):1788-96
pubmed: 7896702
Microbiology. 2008 Feb;154(Pt 2):440-453
pubmed: 18227248
PLoS One. 2015 Jun 26;10(6):e0130639
pubmed: 26114300
Gut Microbes. 2019;10(1):92-99
pubmed: 29913091
Antimicrob Agents Chemother. 2017 Sep 22;61(10):
pubmed: 28807909
Appl Environ Microbiol. 2015 Jul;81(13):4295-305
pubmed: 25888172
Nat Rev Microbiol. 2015 Dec;13(12):777-86
pubmed: 26548913
J Bacteriol. 2008 Jul;190(14):4989-96
pubmed: 18487323
Nat Rev Microbiol. 2010 May;8(5):317-27
pubmed: 20348932
Nat Med. 2019 May;25(5):730-733
pubmed: 31068712
Bioinformatics. 2017 Mar 1;33(5):784-786
pubmed: 28365761
Cell Host Microbe. 2017 Jul 12;22(1):38-47.e4
pubmed: 28704651
J Appl Microbiol. 1998 Sep;85(3):583-90
pubmed: 9750288
Sci Transl Med. 2012 Aug 22;4(148):148ra116
pubmed: 22914622
J Biol Chem. 2010 Dec 17;285(51):39739-49
pubmed: 20959463
J Gen Microbiol. 1972 May;70(3):527-54
pubmed: 4556257
J Bacteriol. 1996 May;178(9):2598-604
pubmed: 8626328
PLoS One. 2013 Dec 09;8(12):e80670
pubmed: 24349011

Auteurs

Shayla Hesse (S)

Laboratory of Molecular Biology, Center for Cancer Research, National Cancer Institute, Bethesda, Maryland, USA shayla.hesse@nih.gov sa4p@nih.gov.

Manoj Rajaure (M)

Laboratory of Molecular Biology, Center for Cancer Research, National Cancer Institute, Bethesda, Maryland, USA.

Erin Wall (E)

Laboratory of Molecular Biology, Center for Cancer Research, National Cancer Institute, Bethesda, Maryland, USA.

Joy Johnson (J)

Laboratory of Molecular Biology, Center for Cancer Research, National Cancer Institute, Bethesda, Maryland, USA.

Valery Bliskovsky (V)

Laboratory of Cancer Biology and Genetics, Center for Cancer Research, National Cancer Institute, Bethesda, Maryland, USA.

Susan Gottesman (S)

Laboratory of Molecular Biology, Center for Cancer Research, National Cancer Institute, Bethesda, Maryland, USA.

Sankar Adhya (S)

Laboratory of Molecular Biology, Center for Cancer Research, National Cancer Institute, Bethesda, Maryland, USA shayla.hesse@nih.gov sa4p@nih.gov.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH